Neogen Corporation (NEOG) stock analysis

Healthcare · Medical Devices

From the 10-K filed 2026-07-30

Business type: Treadmill

How it makes money

Food and feed producers pay for single-use kits to ensure safety.

Customers in the food and animal feed industries purchase diagnostic products to ensure safety. Because the majority of these kits are consumables, such as single-use immunoassay products, Neogen generates recurring revenue every time a customer performs a test.

What protects it: the moat

Neogen claims proprietary testing methodologies protect its market position.

Management asserts that its competitive advantage is based on specialized scientific tools. This includes the use of specific antibodies and genetic testing techniques to produce rapid results.

What growth costs

Neogen invests in new products, international growth, and business acquisitions.

The company pursues growth by introducing new innovations and acquiring other businesses. The integration of the 3M Food Safety division also requires managing duplicative manufacturing costs.

What could damage it

Shifting tariff policies could raise import costs and reduce international sales.

A change in economic policy toward higher tariffs creates a causal chain of risk. Increased duties raise the cost of materials imported into the U.S., while retaliatory measures can hurt sales from international locations.

About Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Other companies in Medical Devices